Medicine

FDA Approves First Treatment for Noncirrhotic Nonalcoholic Steatohepatitis (NASH)

admin March 17, 2024

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) was granted accelerated approval for the treatment of adult patients with noncirrhotic nonalcoholic steatohepatitis (NASH).

LEAVE A RESPONSE Cancel reply

admin

View all posts

Medicine

Merck’s 21-Valent Pneumococcal Conjugate Vaccine Granted FDA Priority Review

admin December 20, 2023

Medicine

Pharma Pulse 7/12/24: The Relationship Between Patients and Drug Shortages, Rise of the Restaurant Robots & more

admin July 14, 2024

Medicine

PrimeRx Launches Digital Platform for Pharmacy Drug Ordering

admin July 7, 2024

Medicine

Will Employers Support Demand for Coverage Expansion of GLP-1 Agonists into Weight Loss?

admin January 13, 2024

Kwarlay.com

Kwarlay.com

FDA Approves First Treatment for Noncirrhotic Nonalcoholic Steatohepatitis (NASH)

LEAVE A RESPONSE Cancel reply

admin

Merck’s 21-Valent Pneumococcal Conjugate Vaccine Granted FDA Priority Review

Pharma Pulse 7/12/24: The Relationship Between Patients and Drug Shortages, Rise of the Restaurant Robots & more

PrimeRx Launches Digital Platform for Pharmacy Drug Ordering

Will Employers Support Demand for Coverage Expansion of GLP-1 Agonists into Weight Loss?

Recent Posts

Archives

Categories

FDA Approves First Treatment for Noncirrhotic Nonalcoholic Steatohepatitis (NASH)

LEAVE A RESPONSE Cancel reply

admin

You Might Also Like

Merck’s 21-Valent Pneumococcal Conjugate Vaccine Granted FDA Priority Review

Pharma Pulse 7/12/24: The Relationship Between Patients and Drug Shortages, Rise of the Restaurant Robots & more

PrimeRx Launches Digital Platform for Pharmacy Drug Ordering

Will Employers Support Demand for Coverage Expansion of GLP-1 Agonists into Weight Loss?

Recent Posts

Archives

Categories